Profile picture

Professor Nebojsa Radovanovic

Emergency Center, Clinical Center of Serbia, University of Belgrade, Belgrade (Serbia)
Membership: FESC Member ACVC Member
Follow
Logo ESC

Contributor content

Adding clinical markers of more severe form of intermediate-high risk pulmonary embolism improves risk stratification and possibly identifies candidates for fibrinolytic therapy
Presentation
Adding clinical markers of more severe form of intermediate-high risk pulmonary embolism improves risk stratification and possibly identifies candidates for fibrinolytic therapy
Read more
Propensity score adjusted analysis of the association of thrombolytic therapy and 30-days outcome in patients with intermediate risk pulmonary embolism
Presentation
Propensity score adjusted analysis of the association of thrombolytic therapy and 30-days outcome in patients with intermediate risk pulmonary embolism
Read more

ESC 365 is supported by

novartis Explore sponsored resources